Strategy

News

Sanofi says new drugs can add €10bn to sales by 2030

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of th

Market Access

A strategic approach to local affiliates in the global era

While global harmonisation remains the holy grail, the reality is that pharmaceutical companies still face significant challenges navigating regulatory differences.

Sales & Marketing

Omnichannel. It’s on every plan, but what’s behind a truly e...

Whether we’re marketing a pharmaceutical brand, diagnostic, device, or medtech product, the need for an omnichannel strategy can’t be ignored.

R&D

Making accessibility strategy part of your rare disease tria...

Over the past several years, diversity, equity, and inclusion (DEI) has become a central subject of conversation in clinical trials.

R&D

New strategies to manage clinical trial risk

It is essential for healthcare and pharmaceutical companies to be aware of both critical and non-critical risks when conducting quality clinical trials.

News

Naoki Okamura named as next CEO of Astellas

Kenji Yasukawa is stepping down as chief executive of Japanese pharma group Astellas, to be succeeded by Naoki Okamura – currently chief strategy officer – on 1st April.